← Full program

  • Research & Academics

Beyond Palliation: Disease Modification with Neuromodulation Therapies

Details

Date
Saturday, January 23, 2027
Time
10:30 AM – 12:00 PM
Room
Milano Ballroom I & II
Session type
Panel Session
Schedule
See this day

About

This panel will review emerging evidence that positions neuromodulation as a restorative and disease-modifying therapy, examining its mechanisms, clinical data, and implications for future research and treatment.

Learning objectives

  • Evaluate emerging clinical evidence supporting disease-modifying effects of neuromodulation therapies.
  • Explain the biological mechanisms that may enable neuromodulation to modify disease processes.
  • Evaluate emerging clinical evidence supporting disease-modifying effects of neuromodulation therapies.

Faculty

  • Maged N. Guirguis, MD

    Maged N. Guirguis, MD

    Department Chairman

    Ochsner Health System · New Orleans, Louisiana

  • Vinny Francio, MD, MS

    Vinny Francio, MD, MS

    Associate Program Director, Assistant Professor

    Washington University School of Medicine in St. Louis · St. Louis, Missouri

  • Erika A. Petersen, MD

    Erika A. Petersen, MD

    Professor

    University of Arkansas for Medical Sciences · Little Rock, Arkansas

  • Sharona Ben-Haim, MD

    Sharona Ben-Haim, MD

    Associate Professor

    University of California, San Diego · CARDIFF BY THE SEA, California

  • Jennifer M. Hah, MD

    Jennifer M. Hah, MD

    Associate Professor

    Stanford Medicine · Stanford, California

Presentations